Notícias IGC Pharma Inc - IGC | Ações American Stock Exchange | ADVFN Brasil

Índice Bovespa

US Dollar vs BRL

As Melhores Corretoras Online

Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

Cadastre-se

Início
Investir
Ações
EUA
AMEX
IGC Pharma Inc (IGC)
IGC Pharma Inc (IGC) Notícias

IGC Pharma Inc (IGC)

0,336

-0,0179

(-5,06%)

Fechado 02 Janeiro 6:00PM

Atrasado por 15 minutos

0,3404

0,0044

(1,31%)

Após o horário de negociação: 9:34PM

Atrasado por 15 minutos

Ferramentas de nível profissional para investidores individuais.

IGC Pharma Announces Additional Phase 2 Interim Results Highlighting Cognitive Benefits of IGC-AD1 for Alzheimer's Treatment

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

IGC Pharma Announces Additional Data Supporting IGC-AD1 as an Alzheimer's Treatment

IGC Pharma Advances IGC-AD1 Toward Clinical Trials as a Potential anti-Amyloid Plaque Treatment for Alzheimer's Disease

IGC Announces Results of its 2024 Annual Stockholders Meeting

IGC Pharma Announces Research Demonstrating New Molecule IGC-1C Targets Tau Protein in Alzheimer's Disease

IGC Pharma Expands Drug Portfolio to Metabolic Disorders with IGC-1A, A Potential New GLP-1 Agonist

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

IGC Pharma Reports First Quarter Fiscal 2025 Results

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

IGC Pharma Announces Equity Analyst Coverage by Alliance Global Partners (AGP) with a "Buy" Recommendation and $3.50 Price Target

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Fóruns

Nenhuma Discussão Encontrada

Criar Nova Discussão

Delayed Upgrade Clock

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições